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Epidemiology of Treponema pallidum, 
Chlamydia trachomatis, Neisseria gonorrhoeae, 
Trichomonas vaginalis, and Herpes simplex virus 
type 2 among female sex workers in the Middle 
East and North Africa: systematic review and 
meta-analytics
Background The epidemiology of sexually transmitted infections (STIs) and the 
role of commercial heterosexual sex networks in driving STI transmission in the 
Middle East and North Africa (MENA) region remain largely unknown.
Objective To characterize the epidemiology of Treponema pallidum (syphilis), Chla-
mydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Herpes simplex 
virus type 2 (HSV-2) among female sex workers (FSWs) in MENA using an in-
depth quantitative assessment.
Methods A systematic review on ten international, regional, and country-lev-
el databases was conducted, and reported following PRISMA guidelines. Pooled 
prevalences of current and/or ever infection for each STI were estimated using 
random-effects meta-analyses. Sources of between-study heterogeneity were in-
vestigated through random-effects meta-regressions.
Results One T. pallidum incidence study and 144 STI prevalence studies were 
identified for 45 812 FSWs in 13 MENA countries. The pooled prevalence of cur-
rent infection was 12.7% (95% confidence interval (CI) = 8.5%-17.7%) for T. pal-
lidum, 14.4% (95% CI = 8.2%-22.0%) for C. trachomatis, 5.7% (95% CI = 3.5%-
8.4%) for N. gonorrhoeae, and 7.1% (95% CI = 4.3%-10.5%) for T. vaginalis. The 
pooled prevalence of ever infection (seropositivity using antibody testing) was 
12.8% (95% CI = 9.4%-16.6%) for T. pallidum, 80.3% (95% CI = 53.2%-97.6%) 
for C. trachomatis, and 23.7% (95% CI = 10.2%-40.4%) for HSV-2. The multivari-
able meta-regression for T. pallidum infection demonstrated strong subregional dif-
ferences, with the Horn of Africa and North Africa showing, respectively 6-fold 
(adjusted odds ratio (AOR): 6.4; 95% CI = 2.5-16.7) and 5-fold (AOR = 5.0; 95% 
CI = 2.5-10.6) higher odds of infection than Eastern MENA. There was also strong 
evidence for declining T. pallidum odds of infection at 7% per year (AOR = 0.93; 
95% CI = 0.88-0.98). Study-specific factors including diagnostic method, sample 
size, sampling methodology, and response rate, were not associated with syphi-
lis infection. The multivariable model explained 48.5% of the variation in T. pal-
lidum prevalence.
Conclusions STI infection levels among FSWs in MENA are considerable, sup-
porting a key role for commercial heterosexual sex networks in transmission dy-
namics, and highlighting the health needs of this neglected and vulnerable pop-
ulation. Syphilis prevalence in FSWs appears to have been declining for at least 
three decades. Gaps in evidence persist for multiple countries.
Electronic supplementary material: 




© 2019 The Author(s)
JoGH © 2019 ISGH
Chemaitelly et al.










The burden of sexually transmitted infections (STIs) and sequelae remains a major global health concern 
[1]. Nearly one million persons are infected with a curable STI every day [2], and about half a billion are 
living with Herpes simplex virus type 2 (HSV-2) [3]. The largely asymptomatic nature of STIs, particularly 
for women, leaves most individuals unaware of their infection [1]. STIs have been associated with HIV 
acquisition [4-6], and poor reproductive health outcomes including pelvic inflammatory disease, ectopic 
pregnancy, infertility, and perinatal deaths [1,7].
Commercial heterosexual sex networks (CHSNs) are believed to play a critical role in STI transmission 
[8-10]. STIs have been demonstrated as proxy biomarkers of sexual risk behaviour [11,12], and as a pow-
erful tool for understanding the structure of sexual networks and predicting HIV epidemic potential [11-
13]. However, unlike HIV, STI epidemiology in CHSNs remains, globally, a neglected area of research [1]. 
Programmatically, STI surveillance among female sex workers (FSWs) continues to be weak and infection 
levels poorly quantified [1]. Sexual propagation of STIs along CHSNs is also poorly understood given the 
dearth or limited validity of self-reported sexual behaviour data [13-15].
To attend to the United Nations’ Sustainable Development Goals (SDGs) and targets [16], particularly 
SDG3 target of “ensuring universal access to sexual and reproductive health services” [16], and to reduce 
the global burden of disease attributed to STIs, the World Health Organization (WHO) has recently for-
mulated the “Global Health Sector Strategy on STIs” [6]. The goal of this strategy is to eliminate STIs as 
a major public health concern by 2030 through an integrated approach for prevention and control [6]. 
Milestones for 2020 include achieving 70% coverage for comprehensive STI prevention services among 
key populations [6]. The strategy’s first strategic direction entails “understanding the STI epidemic as a 
basis for advocacy, political commitment, national planning, resource mobilization and allocation, imple-
mentation, and programme improvement” [6].
Despite remarkable progress in HIV research [17], and an understanding of the role of FSWs [18], peo-
ple who inject drugs (PWID) [19], and men who have sex with men (MSM) [20], in the HIV epidemic 
in the Middle East and North Africa (MENA) region, the epidemiology of STIs and the role of CHSNs in 
driving STI transmission remain largely unknown [21]. The two global reviews of STI epidemiology in 
FSWs had no data for any of the 23 MENA countries [22,23]. A large volume of STI data in the region 
resides in databases that were never analyzed, or in country-level reports that were never published in 
the scientific literature [24,25].
Against this background, our study aimed to characterize the epidemiology of key STIs among FSWs in 
MENA by 1) systematically reviewing and synthesizing all available published and unpublished evidence 
for Treponema pallidum (henceforth referred to as syphilis), Chlamydia trachomatis, Neisseria gonorrhoeae, 
Trichomonas vaginalis, and HSV-2 incidence and/or prevalence, 2) estimating, for each STI, the pooled 
mean prevalence of current and/or ever (seropositivity using antibody testing) infection, and 3) identifying 
sources of between-study heterogeneity, and regional and temporal trends associated with STI prevalence.
METHODS
We conducted a systematic review and an in-depth quantitative assessment to characterize STI epidemi-
ology among FSWs in MENA. Details of the study methodology (including specific statistical analyses) 
can be found in subsequent sections.
Search strategy and selection criteria
Evidence for syphilis, C. trachomatis, N. gonorrhaoeae, T. vaginalis, and HSV-2 immunoglobulin G (IgG) 
incidence and/or prevalence among FSWs in MENA was systematically reviewed, informed by Cochrane’s 
Collaboration guidelines [26]. Findings were reported following Preferred Reporting Items for Systematic 
Reviews and Meta-analyses (PRISMA) guidelines [27] (checklist in Table S1 in Online Supplementary 
Document). The MENA definition covers 23 countries—Afghanistan, Algeria, Bahrain, Djibouti, Egypt, 
Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, Palestine, Qatar, Saudi Arabia, 
Somalia, Sudan, Syria, Tunisia, United Arab Emirates (UAE), and Yemen—based on convention in HIV 
research [19,20,24,25], and definitions of WHO, Joint United Nations Programme on HIV/AIDS (UN-
AIDS), and World Bank [24].
Systematic searches were performed up to September 20, 2018, on international databases (PubMed and 
Embase), regional and national databases (WHO Global Health Observatory data repository [28], WHO 
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African Index Medicus database, WHO Index Medicus for the Eastern Mediterranean Region database, 
Iranian Scientific Information Database, Iraqi Academic Scientific Journals’ database, and Pakistan’s Pak-
MediNet database), abstract archives of International AIDS Society Conferences [29], as well as published 
and unpublished country-level and international organizations’ reports available through the MENA HIV/
AIDS Epidemiology Synthesis Project database [24,25]. Search strings were broad (MeSH/Emtree terms 
exploded to cover all subheadings and free text terms) with no language or year restrictions (Box S1 in 
Online Supplementary Document).
Duplicate citations were identified using a reference manager, Endnote. Titles and abstracts were then 
screened for relevance, with relevant/potentially relevant citations undergoing full-text screening. Any 
document reporting an incidence and/or prevalence measure in FSWs for an STI of interest, based on 
primary data, was eligible for inclusion. Case reports, case series, editorials, commentaries, and reviews 
were excluded. Hand searching was further performed on reference lists of all relevant articles.
The term ‘study’ is used here to refer to a specific STI incidence or prevalence measure in a specific FSW 
population. Accordingly, one document/report could contribute multiple studies and one study could be 
published in different reports. Duplicate study results were included only once using the more detailed/
recent report.
Data extraction and synthesis
Extraction was performed by HC, and double extraction by AS (extraction list in Box S2 in Online Sup-
plementary Document). Discrepancies were settled by consensus, or by contacting authors. Full-texts 
in languages other than English were extracted by native speakers. Data were stratified by infection type 
(current vs ever (seropositivity using antibody testing)), and summarized using medians, ranges, and in-
terquartile ranges (IQR). Definitions of infection types and details of the classification of diagnostic meth-
ods’ results into current, recent, and ever infection can be found in Table S2 in Online Supplementary 
Document. It was assumed, for N. gonorrhoeae and T. vaginalis studies, whenever a diagnostic method 
was not explicitly specified, that the diagnostic method assessed current infection.
All STI studies were extracted and reported. However, studies applying the same assay to different biolog-
ical specimens from the same person were included only once in analyses, for statistical independence. 
This was done based on a sequential order that prioritized infection detection in endocervical swabs, fol-
lowed by vaginal, then urine samples. Studies assessing prevalence using different diagnostic methods, 
were also included only once in analyses, with studies using polymerase chain reaction prioritized over 
those using culture or other methods.
Quality assessment
The quality assessment for each STI prevalence study was informed by Cochrane Collaboration guidelines 
(criteria in Table S3 in Online Supplementary Document) [30]. Studies were classified as having “low” 
vs “high” risk of bias (ROB) on each of three quality domains assessing the 1) rigor of sampling method-
ology (probability-based; non-probability-based), 2) response rate (≥60% or ≥60% of target sample size 
reached for studies using respondent-driven or time-location sampling; <60%), and 3) STI ascertainment 
(biological assay explicitly indicated; otherwise). Studies with missing information for a specific domain 
were classified as having “unclear” ROB for that domain.
Given reported limitations in HSV-2 diagnostics [31,32], the quality of HSV-2 assays was determined by 
consulting with an expert advisor, Professor Rhoda Ashley-Morrow, University of Washington, Seattle. Stud-
ies where the validity of the diagnostic method could not be confirmed, were excluded from the systemat-
ic review.
Quality domains were included in meta-regression analyses (described below) to assess their impact on 
prevalence.
Meta-analyses
For each STI, the pooled mean prevalence of current and/or ever infection, along with the corresponding 
95% confidence intervals (CIs), were estimated using meta-analysis. Overall prevalence measures were 
replaced by their strata where applicable. For each study, one final stratification was considered based on 
a pre-defined sequential order that prioritizes country of origin, followed by type of FSW, year, region, 
and age. Subregional and time-trend analyses were conducted as warranted by data. Variances were stabi-
lized using Freeman-Tukey type arcsine square-root transformation [33,34]. Weights were applied using 
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the inverse-variance method [34,35], before pooling measures using a Dersimonian-Laird random-effects 
model [36], thereby accounting for sampling variation and for true heterogeneity [37]. Missing sample 
sizes for measures or their strata (<4% of all studies) were imputed using the median sample size, as cal-
culated from studies with available information.
Heterogeneity assessment used Cochran’s Q statistic to confirm existence of heterogeneity across studies, 
I2 to determine magnitude of between-study variation that is due to true differences in effect size (prev-
alence) rather than chance, and prediction intervals to estimate the 95% interval of the true effect sizes’ 
distribution [37,38].
Meta-analyses were implemented in R 3.4.2 (R core team, Vienna, Austria) [39].
Meta-regressions
Only syphilis had a considerable number of measures (>100) to warrant conduct of random-effects me-
ta-regression analyses. Independent variables considered a priori were: country/subregion, year of data 
collection, infection type, diagnostic method, STI ascertainment, sample size, sampling methodology, and 
response rate. Details of subgrouping and justifications are in Table S4 in Online Supplementary Doc-
ument. Meta-regression was conducted using the log-transformed odds of syphilis infection and corre-
sponding variance. Factors associated with higher odds of infection at P ≤ 0.10 in univariable analyses were 
included in the multivariable analysis. Factors with P ≤ 0.05 in the multivariable model were considered 
as significant predictors of heterogeneity in syphilis prevalence.
Meta-regressions were implemented in Stata/SE 15.1 (StataCorp, College Station, TX, USA) [40].
Figure 1. Flowchart presenting the process of study selection following PRISMA guidelines [27].
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Search results and scope of evidence
Figure 1 shows the study selection process based on PRISMA. The search identified a total of 11 832 ci-
tations: 240 through PubMed, 1949 through Embase, and 9643 through the rest of the databases. After 
removing duplicates and screening of titles and abstracts, 157 reports qualified for full-text screening, of 
which 31 were eligible for inclusion in the systematic review.
Thirteen additional reports, two of which replaced eligible articles, and four additional STI measures, 
were further identified through the MENA HIV/AIDS Epidemiology Synthesis Project database. Fourteen 
additional syphilis prevalence measures were identified through the WHO Global Health Observatory 
data repository. Two studies were excluded based on consultation with Professor Rhoda Ashley-Morrow, 
an expert advisor in HSV-2 diagnostics, because the validity of the type-specific HSV-2 serology could 
not be confirmed [41,42].
In sum, 42 eligible reports and 18 additional STI measures were included in the systematic review. These 
yielded one syphilis incidence study, and 144 prevalence studies assessing the different STIs. The latter 
contributed 173 stratified measures for inclusion in meta-analyses and meta-regressions.
STI prevalence data were available for 45 812 FSWs from 13 of the 23 MENA countries. Nearly two-thirds 
(58.9%) of prevalence studies assessed syphilis (in 29 769 FSWs), 16.3% assessed C. trachomatis (in 5613 
FSWs), 12.8% assessed N. gonorrhoeae (in 5230 FSWs), 8.5% assessed T. vaginalis (in 4258 FSWs), and 
3.6% assessed HSV-2 IgG (in 942 FSWs). Most studies (80.8%) were conducted post-2000. Over half 
(51.1%) of studies reported on current infection, 30.5% on ever infection (seropositivity using antibody 
testing), and 1.4% on recent infection. Time of exposure was unclear for the rest of studies (17.0%).
Incidence studies
The only one identified incidence study assessed syphilis incidence in FSWs. The study was conduct-
ed in 1988 in Mogadishu, Somalia, and reported cumulative incidence at 12.5% after six months of fol-
low-up [43].
Prevalence studies
Prevalence of current syphilis infection among FSWs ranged, across studies (n = 28), from 0%-50.8%, 
with a median of 9.4% (IQR: 3.0%-23.4%; Table 1). Meanwhile, seropositivity for syphilis (n = 33) anti-
bodies ranged from 0%-69.0%, with a median of 4.2% (IQR: 1.9%-15.2%).
Current C. trachomatis infection prevalence (n = 14) ranged from 0.7%-72.9%, with a median of 7.7% 
(IQR = 1.7%-22.4%), while seropositivity prevalence using IgG (n = 5) ranged from 19.8%-100%, with 
a median of 85.8% (IQR = 46.8%-97.1%; Table 2). Two studies reported recent C. trachomatis infection 
(assessed using serological biomarkers) at 29.2% [79] and 95.0% [78].
Current N. gonorrhoeae infection prevalence (n = 18) ranged from 0%-14.5%, with a median of 7.6% (IQR 
= 1.3%-11.1%; Table 2). Current T. vaginalis infection prevalence (n = 12) ranged from 0%-19.3%, with a 
median of 7.0% (IQR = 4.5%-14.2%; Table 2). HSV-2 seropositivity (using IgG; n = 5) ranged from 4.7%-
55.5%, with a median of 20.0% (IQR = 6.4%-39.1%; Table 3).
Quality assessment
The summarized and study-specific ROB assessments of prevalence measures are in Tables S5 and S6 in 
Online Supplementary Document, respectively. Briefly, nearly half of studies (44.7%) used probabili-
ty-based sampling. Most studies (78.7%) indicated explicitly the biological assay used for STI ascertain-
ment. Response rate information was missing in over half of studies (51.8%).
Overall, studies were of reasonable quality. Close to 60% of studies had low ROB on at least two quality 
domains, and none had high ROB on two or more domains.
Pooled mean prevalence estimates
Table 4 shows the results of meta-analyses estimating the pooled mean prevalence of current and/or ever 
infection for each STI. The mean prevalence of current infection was estimated at 12.7% (95% CI = 8.5%-
Chemaitelly et al.
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17.7%) for syphilis, 14.4% (95% CI = 8.2%-22.0%) for C. trachomatis, 5.7% (95% CI = 3.5%-8.4%) for 
N. gonorrhoeae, and 7.1% (95% CI = 4.3%-10.5%) for T. vaginalis.
The mean prevalence of ever infection was estimated at 12.8% (95% CI = 9.4%-16.6%) for syphilis, 80.3% 
(95% CI = 53.2%-97.6%) for C. trachomatis, and 23.7% (95% CI = 10.2%-40.4%) for HSV-2 IgG.
There was strong evidence for heterogeneity in effect size (here, prevalence). P for Cochran’s Q statistic 
was always <0.0001. I2 was >90% in all meta-analyses, indicating that most variability is due to true dif-
ferences in effect size across studies, rather than being due to chance. Prediction intervals were also wide 
affirming high heterogeneity.
Additional meta-analyses at the subregional level indicated the mean prevalence of current syphilis infec-
tion at 3.0% (95% CI = 0.9%-9.2%) in Eastern MENA, 17.6% (95% CI = 14.2%-21.3%) in North Africa, 
and 27.8% (95% CI = 15.2%-42.4%) in the Horn of Africa (Table S7 in Online Supplementary Docu-
ment). There was also a tendency for a decline in current infection prevalence post-2010 (Table S8 and 
Figure S1A in Online Supplementary Document). For the rest of the STIs, the number of studies was 
small and the CIs were wide and overlapping to warrant conclusive statement about the temporal trend 
(Table S8 in Online Supplementary Document).
Predictors of variability in syphilis infection
Country/subregion, year of data collection, diagnostic method, sample size, sampling methodology, and 
response rate were associated with higher odds of syphilis infection in the univariable meta-regression 
analyses. These were, therefore, included in the multivariable model (Table 5). About a third of the vari-
ability was explained by each of year of data collection and subregion (adjusted R-squared: 34.6% and 
31.5%, respectively). Meanwhile, no evidence for an association with infection type (current infection; 
ever infection), or STI ascertainment (biological assay explicitly indicated; otherwise) was found.
The multivariable analysis showed strong evidence for subregional differences, with Horn of Africa and 
North Africa showing, respectively, 6-fold (adjusted odds ratio (AOR): 6.4; 95% CI = 2.5-16.7) and 5-fold 
(AOR = 5.0; 95% CI = 2.5-10.6), higher odds of syphilis infection than Eastern MENA.
There was also strong evidence for a temporal trend of decreasing odds of infection at 7% per year 
(AOR = 0.93; 95% CI = 0.88-0.98; linearity dictated by data (Figure S1 in Online Supplementary Docu-
ment) over the last three decades. Although this trend was noted in all subregions, individual subregion 
meta-regressions were not always powered to detect statistical significance (not shown).
No evidence for an association with diagnostic method, sample size, sampling methodology, and response 
rate was identified in the multivariable model. The multivariable model explained 48.5% of variation in 
syphilis prevalence.
DISCUSSION
We provided, to our knowledge, the first detailed assessment of the epidemiology of key STIs in FSWs in 
MENA, a neglected key population. Our findings indicated substantial STI prevalence, several folds high-
er than that among the general population [2,13,24,86]. These findings suggest a major role for CHSNs 
in driving STI transmission in MENA. We further found large heterogeneity in syphilis infection levels by 
subregion within MENA, as well as a trend of decreasing odds of infection by ~ 7% per year – less than the 
17% [86] annual decline needed to achieve the target of 90% reduction in syphilis incidence by 2030 [6].
Despite the significant infection burden, STI surveillance and response in MENA continue to be rudimen-
tary [21], and far below the coverage targets of WHO Global Health Sector Strategy for STIs [6]. Infected 
individuals are often identified through routine case notifications with surveillance/testing being large-
ly limited to HIV [21,24,87], and sexual health programs, where they exist, cater to general population 
women rather than women at high risk [24].
Although our expansive search identified considerable evidence at the regional-level, including data that 
will appear in the scientific literature for the first time, evidence varied by country. Over half of coun-
tries had no data on any of the STIs in this key population, less than a third had data on C. trachoma-
tis, N. gonorrhoeae, or T. vaginalis, and only three countries had data on HSV-2 IgG (Table 1, Table 2 
and Table 3). This outcome is of concern, given the considerable, yet preventable, STI infection burden 
among FSWs in the region (Table 4), and the major “core group” role that CHSNs play in STI transmis-
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sion in any population [10]. Indeed, while the 
population proportion of FSWs (proportion 
of FSWs out of the total women population) 
varies across countries and may seem relative-
ly small [18,88], the size of CHSNs is large 
suggesting a considerable number of women 
and men at risk of STI-related morbidity, ei-
ther through engagement in high sexual risk 
behavior, or through onward infection trans-
mission [89].
Availability of STI data stands in contrast to 
HIV data, for which the volume of evidence 
among FSWs was several fold higher and en-
compassed most countries [18]. Attending to 
WHO Global Health Sector Strategy on STIs 
[6] necessitates a major expansion of STI re-
search and surveillance, as has been done 
for HIV [17,87,90]. Regrettably, integrated 
bio-behavioural surveillance surveys (IBBSS) 
among key populations continue to be focused 
on HIV, rarely incorporating STIs [91,92]. 
This presents an important, yet lost, oppor-
tunity for monitoring STI levels and trends 
in key populations, informing programming 
efforts, gaining an in-depth understanding of 
sexual networks’ structure, and advancing STI 
research in this region [13,91,93].
Subregion and time explained most varia-
tion in syphilis prevalence—each explained 
over a third of the variation, and both (re-
markably) explained ~ 50% of the variation 
(Table 5). The strong subregional differenc-
es, with Horn of Africa showing the highest 
prevalence, followed by North Africa, and 
then Eastern MENA (Table 5 and Table S7 in 
Online Supplementary Document), appear 
to reflect variability in the risk environment, 
such as differences in structure of sexual net-
works [24], condom use [18], and access to 
care [24]. The same pattern has been seen in 
HIV epidemiology among FSWs [18].
There was strong evidence for a time trend of 
decreasing odds of infection at ~ 7% per year 
(Table 5, and Table S8 and Figure S1 in the 
OSD), consistent with, but smaller than, the 
decline reported for the general population in 
MENA in a recent global analysis [86], and 
the declines reported for the general popula-
tions in other regions [86]. Different factors 
may have contributed to this trend including 
safer sex following the HIV epidemic [94], 
increased condom use to prevent unwant-
ed pregnancy [18], and HIV-related mortali-
ty which may have disproportionally affected 
populations at higher risk of STIs [95]. This 
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duration of active syphilis infection in FSWs or their sex partners [96,97], possibly because of improve-
ments in syphilis diagnostics and treatment, or because of widespread use of antibiotics (including for 
non-STI infections, which sometimes may cure concurrent syphilis) [86].
This being said, recent surveillance data seems also to suggest an increase in syphilis incidence and/or 
prevalence in other sexual networks or in specific settings, such as among MSM [98-100], and even among 
reproductive-age women in few countries where congenital syphilis appears to be rising [101,102]. Con-
tributors to these trends may include behavioral factors, such as more sexual partners and unprotected 
sex among MSM, as well as contextual factors, and possibly even biological factors [99,100,102-104].
Prevalence measures for syphilis and for C. trachomatis in FSWs in MENA were comparable to global levels 
[22,23], but prevalence measures for N. gonorrhoeae and T. vaginalis leaned towards the lower end of the 
global range [22,23]. Even though the risk environment among FSWs in MENA seems less conducive to 
STI transmission, as compared to other regions [18], STI prevalence levels are substantial, perhaps affect-
ed by poor access to health care and prevention interventions [21,24,105], as well as absence of enabling 
environments for this vulnerable population, in a context of criminality [106,107] and stigma [108-110].
While interventions aiming at promoting safer sex, such as condom use, and STI etiological diagnosis and 
treatment, in high risk populations are widely accepted and advocated for [6,111-114], STI syndrom-
ic case management and presumptive treatment have been increasingly subject to criticism amid grow-
ing concerns about their role in promoting pathogens’ antimicrobial resistance (AMR) [111,115-119]. 
Indeed, substantial AMR prevalence and multiple drug resistant strains have been found in gonococcal 
isolates from FSWs in sub-Saharan Africa [120,121] and elsewhere [122]. This suggests that despite the 
effectiveness of targeted STI treatment services in reducing STI incidence and prevalence, their appropri-
ateness and sustainable implementation will need to be informed by surveillance and monitoring, nota-
bly for AMR, and thus may vary across settings [111,122]. This further supports WHO efforts towards 
building a global business case for accelerating development of STI vaccines as a fundamental solution 
to STI drug resistance [123-125].
This study is limited by the quantity and quality of available data. STI prevalence among FSWs remains 
unknown in over half of countries. While there was considerable evidence for syphilis, less evidence was 
found for C. trachomatis, N. gonorrhoeae, T. vaginalis, and HSV-2, limiting our ability to conduct advanced 
meta-analytics—meta-regressions were carried out only for syphilis. Though, for syphilis prevalence, the 
differences between current vs ever (seropositivity using antibody testing) infection, as well as the dif-
ferences between diagnostics, were consistent with the findings of a large global analysis for the general 
population [86], the confidence intervals were wide owing to the smaller number of studies (Table 5). 
Several measures were based on routine data reporting, and did not include sufficient documentation of 
study methodology. There was also a wide array of diagnostics used for STI ascertainment, which may 
have affected observed prevalence.
Available studies may not be representative of the wider population of FSWs, or could be subject to bias-
es, such as selection bias or detection bias. Of note, however, that there was no evidence that any of the 
assessed study-specific quality domains (Tables S5-S6 in Online Supplementary Document), including 
sampling methodology, response rate, and explicit indication of the assay used for infection ascertain-
ment, had an effect on prevalence in the multivariable meta-regression (Table 5). Despite limitations, our 
study provided a detailed synthesis of STI epidemiology in FSWs in MENA, in a background of lack of 
evidence for this region [22,23]. A significant volume of published and unpublished data was identified 
and analyzed, and for the first time.
In conclusion, STI levels among FSWs are considerable, supporting a key role for CHSNs in STI trans-
mission dynamics in MENA, and highlighting the public health needs of this neglected and vulnerable 
population. Despite the progress in our epidemiological understanding, major gaps persist, with no ev-
idence being available for over half of MENA countries. With the limited STI surveillance [24,126], and 
the focus of programmatic response on case management and syndromic approach, rather than being 
evidence-informed and grounded on etiological studies [24,126], there is a critical need to expand STI 
surveillance and the broader STI research agenda. STI testing should be part of IBBSS studies, as well as 
part of voluntary counseling and testing services for HIV [91,93]. Interventions should factor research 
findings to ensure adequate and efficient resource allocation. Without such expansion of STI efforts, it 
will not be possible to monitor infection trends, or to inform a public health response that attends to the 
WHO Global Health Sector Strategy on STIs [6].
Chemaitelly et al.
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